Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

News in Brief

Device Captures CTC Clusters in Blood

DOI: 10.1158/2159-8290.CD-NB2015-095 Published September 2015
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Individual blood-borne tumor cells have been linked to metastasis in patients with cancer, and clusters of these circulating tumor cells (CTC) spell an even worse prognosis. To facilitate the study of these aggregates, researchers have created Cluster-Chip, a microfluidic device that captures CTC clusters directly from the blood without using antibodies or chemical labels.

Isolating CTCs is tricky because they are uncommon—about one per billion cells in blood—and CTC clusters are rarer still. Many methods use antibodies, which bind CTCs in order to capture them directly or bind other blood cells in order to separate them from CTCs. However, because antibody strength and specificity often vary and CTCs can be heterogeneous in their expression of surface markers, antibody-based techniques are not ideal.

Cluster-Chip, on the other hand, is “antigen-agnostic,” says A. Fatih Sarioglu, PhD, a biomedical engineer at Georgia Institute of Technology in Atlanta. Unlike other methods that target single CTCs with the hope of capturing clusters, the new device, Sarioglu says, is specifically designed to catch clumps of CTCs.

Figure1

Scanning electron micrograph of Cluster-Chip shows rows of triangular pillars that trap CTC clusters.

Sarioglu and molecular biologist Nicola Aceto, PhD, of Massachusetts General Hospital (MGH) in Boston, are co–first authors of a paper describing Cluster-Chip (Nat Methods 2015;12:685–91). They initiated the research while working with Mehmet Toner, PhD, and Daniel Haber, MD, PhD, at MGH.

Figure2

A three-cell cluster of fluorescently labeled human prostate adenocarcinoma cells captured on Cluster-Chip.

Measuring about 7.50 cm × 3.75 cm, Cluster-Chip is a glass slide that traps CTC clusters as blood passes through a matrix of triangular pillars with 12-μm gaps between vertices. Although CTCs are slightly larger (about 15 μm wide), single cells are squishy and easily squeeze through the matrix. However, CTC clusters catch on the points of the triangular pillars and remain trapped on the slide.

To measure the device's capture efficiency, the researchers spiked healthy human blood samples with clusters of fluorescently labeled MDA-MB-231 human breast cancer cells. Cluster-Chip captured 99% of clusters containing at least four tumor cells, 70% of three-cell clusters and 41% of two-cell clusters. For optimal performance, the researchers used a flow rate about 10 times slower than normal blood circulation and processed samples at 4°C instead of room temperature.

Compared with other methods, Sarioglu says, Cluster-Chip may give a truer estimate of how common CTC clusters are. When used on blood samples from 60 patients with metastatic breast or prostate cancer or with melanoma, CTC clusters were found in 30% to 40% of patients. Earlier experiments with antibody-based microfluidic tools developed by the same researchers detected CTC clusters in only 5% to 10% of patient samples.

Chwee Teck Lim, PhD, of the National University of Singapore, says devices like Cluster-Chip provide a “means of capturing circulating tumor microemboli.” Isolating CTC clusters can give insight into their role and function, including how they might differ from single CTCs. For example, “Do CTC clusters contain specific subpopulations of CTCs that make them more likely to metastasize?” Lim asks. “We do not know yet.”

Notes

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.

  • ©2015 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 5 (9)
September 2015
Volume 5, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Device Captures CTC Clusters in Blood
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Device Captures CTC Clusters in Blood
Cancer Discov September 1 2015 (5) (9) 898-899; DOI: 10.1158/2159-8290.CD-NB2015-095

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Device Captures CTC Clusters in Blood
Cancer Discov September 1 2015 (5) (9) 898-899; DOI: 10.1158/2159-8290.CD-NB2015-095
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CAR Ts and BiTEs Shine in Multiple Myeloma
  • “A Complete Molecular Atlas of Glioblastoma”
  • TROP2 ADC Intrigues in NSCLC
Show more News in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement